Literature DB >> 21325196

Cell therapy for critical limb ischemia: moving forward one step at a time.

Rajesh Gupta, Douglas W Losordo.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21325196      PMCID： PMC3123778          DOI： 10.1161/CIRCINTERVENTIONS.110.960716

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  21 in total

1.  Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease).

Authors:  Leslie T Cooper; Tak Sun Tse; Michael A Mikhail; Robert D McBane; Anthony W Stanson; Karla V Ballman
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 3.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Jeffrey W Olin; Anthony Shih
Journal:  Curr Opin Rheumatol       Date:  2006-01       Impact factor: 5.006

4.  Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization.

Authors:  William A Marston; Stephen W Davies; Brian Armstrong; Mark A Farber; Robert C Mendes; Joseph J Fulton; Blair A Keagy
Journal:  J Vasc Surg       Date:  2006-07       Impact factor: 4.268

5.  Impaired progenitor cell activity in age-related endothelial dysfunction.

Authors:  Christian Heiss; Stefanie Keymel; Ulrike Niesler; Jutta Ziemann; Malte Kelm; Christoph Kalka
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

6.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

Review 7.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

8.  Clinical and social consequences of Buerger disease.

Authors:  Takashi Ohta; Hiroyuki Ishioashi; Minoru Hosaka; Ikuo Sugimoto
Journal:  J Vasc Surg       Date:  2004-01       Impact factor: 4.268

9.  Evidence for circulating bone marrow-derived endothelial cells.

Authors:  Q Shi; S Rafii; M H Wu; E S Wijelath; C Yu; A Ishida; Y Fujita; S Kothari; R Mohle; L R Sauvage; M A Moore; R F Storb; W P Hammond
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

10.  Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.

Authors:  Christopher Heeschen; Ralf Lehmann; Jörg Honold; Birgit Assmus; Alexandra Aicher; Dirk H Walter; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2004-03-22       Impact factor: 29.690
View more
  14 in total

1.  Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model.

Authors:  Jessica A DeQuach; Joy E Lin; Cynthia Cam; Diane Hu; Michael A Salvatore; Farah Sheikh; Karen L Christman
Journal:  Eur Cell Mater       Date:  2012-06-05       Impact factor: 3.942

2.  Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: implications for ischemic cardiovascular disease.

Authors:  Akm Khyrul Wara; Kevin Croce; ShiYin Foo; Xinghui Sun; Basak Icli; Yevgenia Tesmenitsky; Fehim Esen; Anthony Rosenzweig; Mark W Feinberg
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

3.  Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.

Authors:  Kenneth S Cohen; Susan Cheng; Martin G Larson; L Adrienne Cupples; Elizabeth L McCabe; Ying A Wang; Julius S Ngwa; Roderick P Martin; Rachael J Klein; Basma Hashmi; Yin Ge; Christopher J O'Donnell; Ramachandran S Vasan; Stanley Y Shaw; Thomas J Wang
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

4.  An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model.

Authors:  Jennifer Whiteley; Ryszard Bielecki; Mira Li; Shawn Chua; Michael R Ward; Nobuko Yamanaka; Duncan J Stewart; Robert F Casper; Ian M Rogers
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

5.  Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.

Authors:  Emerson C Perin; Michael Murphy; John P Cooke; Lem Moyé; Timothy D Henry; Judy Bettencourt; Amir Gahremanpour; Nicholas Leeper; R David Anderson; William R Hiatt; Joao A Lima; Bharath Venkatesh; Shelly L Sayre; Rachel W Vojvodic; Doris A Taylor; Ray F Ebert; Alan T Hirsch
Journal:  Am Heart J       Date:  2014-07-30       Impact factor: 4.749

6.  Photoluminescent oxygen-release microspheres to image the oxygen release process in vivo.

Authors:  Ya Guan; Hong Niu; Yu Dang; Ning Gao; Jianjun Guan
Journal:  Acta Biomater       Date:  2020-08-25       Impact factor: 8.947

7.  Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: towards clinical studies in ischaemic disease.

Authors:  A Kaupisch; L Kennedy; V Stelmanis; B Tye; N M Kane; J C Mountford; A Courtney; A H Baker
Journal:  J Cardiovasc Transl Res       Date:  2012-08-02       Impact factor: 4.132

8.  Endothelial sprouting and network formation in collagen- and fibrin-based modular microbeads.

Authors:  Ana Y Rioja; Ramkumar Tiruvannamalai Annamalai; Spencer Paris; Andrew J Putnam; Jan P Stegemann
Journal:  Acta Biomater       Date:  2015-10-23       Impact factor: 8.947

9.  MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.

Authors:  Gaia Spinetti; Orazio Fortunato; Andrea Caporali; Saran Shantikumar; Micol Marchetti; Marco Meloni; Betty Descamps; Ilaria Floris; Elena Sangalli; Rosa Vono; Ezio Faglia; Claudia Specchia; Gianfranco Pintus; Paolo Madeddu; Costanza Emanueli
Journal:  Circ Res       Date:  2012-12-11       Impact factor: 17.367

10.  Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System.

Authors:  Venkatesh Ponemone; Saniya Gupta; Dalip Sethi; Manish Suthar; Monika Sharma; Richard J Powell; Kenneth Lee Harris; Nungshi Jungla; Priyadarshini Arambam; Upendra Kaul; Ashok Seth; Suhail Bukhari
Journal:  Stem Cells Int       Date:  2017-01-17       Impact factor: 5.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.